Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarizotan in Neuroleptic-induced Tardive Dyskinesia
NCT00310661Phase 2Terminated
- Sponsor
- Center for Addiction and Mental Health
- Start
- Dec 2004
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sarizotan in tardive dyskinesia (TD), sponsored by Center for Addiction and Mental Health. Started Dec 2004; status: terminated.
02
Drugs
sarizotan
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT00310661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310661.